Document is current
Any future updates will be listed below
-
Authors
Mars, Sarah https://orcid.org/0000-0002-7109-8602
Ondocsin, Jeff
Koester, Kimberly A.
Mars, Valerie
Mars, Gerald
Ciccarone, Daniel
-
Funding
Funding for this research was provided by:
National Institutes of Health, National Institute on Drug Abuse (DA037820)
National Institutes of Health UCSF-Gladstone Center for AIDS Research (P30AI027763)
University of California San Francisco, AIDS Research Institute
- License Information
-
More Information
Article History
Accepted: 29 June 2024
First Online: 15 July 2024
Declarations
:
: Dr. Daniel Ciccarone reports the following relevant financial relationships during the past 12 months: 1, he is a scientific advisor to Celero Systems and 2, he has been retained as an expert witness in ongoing prescription opioid litigation by Motley Rice, LLP. The remaining authors have no relevant financial or non-financial interests to disclose.
: The methodology of this study was approved by the Committee on Human Research of the University of California San Francisco, Institutional Review Board number 18-27035.
: This is an original submission that has not been submitted or published elsewhere.
: Informed consent was obtained from all individual participants included in the study and, where quotations have been used, for these to be published in a journal article.
